vs

Side-by-side financial comparison of Axogen, Inc. (AXGN) and Clipper Realty Inc. (CLPR). Click either name above to swap in a different company.

Axogen, Inc. is the larger business by last-quarter revenue ($61.5M vs $37.1M, roughly 1.7× Clipper Realty Inc.). Clipper Realty Inc. runs the higher net margin — -30.4% vs -31.9%, a 1.5% gap on every dollar of revenue. On growth, Axogen, Inc. posted the faster year-over-year revenue change (26.6% vs -2.6%). Over the past eight quarters, Axogen, Inc.'s revenue compounded faster (13.3% CAGR vs 1.8%).

Axogen is a developer of surgical solutions, including human tissue grafts, based in Alachua, Florida. Axogen products are designed to remedy peripheral nerve damage. In 2013 the company raised $18 million in its initial public offering (IPO). Axogen uses a cell graft technology AVANCE to mimic a human nerve. The company also creates nerve connectors and soft tissue membranes. The company reports sensory and movement recovery in 87 percent of patients with peripheral nerve injuries. Axogen is...

Clipper Equity LLC is a partnership led by David Bistricer and Sam Levinson. The firm owns more than 60 buildings, with thousands of residential units, in New York and New Jersey. The partnership are known for their attempted purchase of the Starrett City housing complex in Brooklyn, New York, for $1.3 billion on February 8, 2007, in one of the largest real estate transactions in history. New York's Mayor Michael Bloomberg expressed concerns over the new landlord's history of building violati...

AXGN vs CLPR — Head-to-Head

Bigger by revenue
AXGN
AXGN
1.7× larger
AXGN
$61.5M
$37.1M
CLPR
Growing faster (revenue YoY)
AXGN
AXGN
+29.1% gap
AXGN
26.6%
-2.6%
CLPR
Higher net margin
CLPR
CLPR
1.5% more per $
CLPR
-30.4%
-31.9%
AXGN
Faster 2-yr revenue CAGR
AXGN
AXGN
Annualised
AXGN
13.3%
1.8%
CLPR

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
AXGN
AXGN
CLPR
CLPR
Revenue
$61.5M
$37.1M
Net Profit
$-19.6M
$-11.3M
Gross Margin
75.2%
-5.2%
Operating Margin
20.2%
21.8%
Net Margin
-31.9%
-30.4%
Revenue YoY
26.6%
-2.6%
Net Profit YoY
-410.8%
-938.6%
EPS (diluted)
$-0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AXGN
AXGN
CLPR
CLPR
Q1 26
$61.5M
Q4 25
$59.9M
$37.1M
Q3 25
$60.1M
$37.7M
Q2 25
$56.7M
$39.0M
Q1 25
$48.6M
$39.4M
Q4 24
$49.4M
$38.0M
Q3 24
$48.6M
$37.6M
Q2 24
$47.9M
$37.3M
Net Profit
AXGN
AXGN
CLPR
CLPR
Q1 26
$-19.6M
Q4 25
$-13.2M
$-11.3M
Q3 25
$708.0K
$-4.6M
Q2 25
$579.0K
$-1.4M
Q1 25
$-3.8M
$-35.1M
Q4 24
$450.0K
$-1.1M
Q3 24
$-1.9M
$-1.1M
Q2 24
$-1.9M
$-1.7M
Gross Margin
AXGN
AXGN
CLPR
CLPR
Q1 26
75.2%
Q4 25
74.1%
-5.2%
Q3 25
76.6%
23.6%
Q2 25
74.2%
27.8%
Q1 25
71.9%
-34.5%
Q4 24
76.1%
28.8%
Q3 24
74.9%
28.6%
Q2 24
73.8%
26.8%
Operating Margin
AXGN
AXGN
CLPR
CLPR
Q1 26
20.2%
Q4 25
-16.3%
21.8%
Q3 25
3.2%
23.6%
Q2 25
3.0%
27.7%
Q1 25
-3.4%
-59.9%
Q4 24
4.1%
28.1%
Q3 24
-0.6%
28.6%
Q2 24
-0.9%
26.8%
Net Margin
AXGN
AXGN
CLPR
CLPR
Q1 26
-31.9%
Q4 25
-22.0%
-30.4%
Q3 25
1.2%
-12.2%
Q2 25
1.0%
-3.5%
Q1 25
-7.9%
-89.1%
Q4 24
0.9%
-2.9%
Q3 24
-3.8%
-2.9%
Q2 24
-4.0%
-4.7%
EPS (diluted)
AXGN
AXGN
CLPR
CLPR
Q1 26
$-0.38
Q4 25
$-0.28
Q3 25
$0.01
Q2 25
$0.01
Q1 25
$-0.08
Q4 24
$-0.00
Q3 24
$-0.04
Q2 24
$-0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AXGN
AXGN
CLPR
CLPR
Cash + ST InvestmentsLiquidity on hand
$82.7M
$30.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$244.8M
$-30.7M
Total Assets
$289.5M
$1.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AXGN
AXGN
CLPR
CLPR
Q1 26
$82.7M
Q4 25
$41.5M
$30.8M
Q3 25
$35.8M
$26.1M
Q2 25
$29.9M
$32.0M
Q1 25
$22.1M
$21.3M
Q4 24
$33.5M
$19.9M
Q3 24
$24.5M
$18.6M
Q2 24
$21.1M
$20.3M
Total Debt
AXGN
AXGN
CLPR
CLPR
Q1 26
Q4 25
$48.4M
Q3 25
$48.2M
Q2 25
$47.9M
Q1 25
$47.7M
$1.3B
Q4 24
$47.5M
$1.3B
Q3 24
$47.3M
$1.3B
Q2 24
$47.0M
$1.2B
Stockholders' Equity
AXGN
AXGN
CLPR
CLPR
Q1 26
$244.8M
Q4 25
$128.8M
$-30.7M
Q3 25
$120.8M
$-25.0M
Q2 25
$112.3M
$-21.9M
Q1 25
$105.4M
$-20.1M
Q4 24
$103.9M
$-5.4M
Q3 24
$99.4M
$-3.6M
Q2 24
$95.7M
$-1.8M
Total Assets
AXGN
AXGN
CLPR
CLPR
Q1 26
$289.5M
Q4 25
$221.7M
$1.2B
Q3 25
$216.4M
$1.2B
Q2 25
$205.5M
$1.2B
Q1 25
$196.2M
$1.3B
Q4 24
$203.7M
$1.3B
Q3 24
$192.0M
$1.3B
Q2 24
$188.9M
$1.3B
Debt / Equity
AXGN
AXGN
CLPR
CLPR
Q1 26
Q4 25
0.38×
Q3 25
0.40×
Q2 25
0.43×
Q1 25
0.45×
Q4 24
0.46×
Q3 24
0.48×
Q2 24
0.49×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AXGN
AXGN
CLPR
CLPR
Operating Cash FlowLast quarter
$22.6M
Free Cash FlowOCF − Capex
$-1.4M
FCF MarginFCF / Revenue
-2.3%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$9.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AXGN
AXGN
CLPR
CLPR
Q1 26
Q4 25
$3.0M
$22.6M
Q3 25
$3.2M
$1.4M
Q2 25
$7.7M
$8.4M
Q1 25
$-13.2M
$6.7M
Q4 24
$8.7M
$31.9M
Q3 24
$3.9M
$6.3M
Q2 24
$4.2M
$8.8M
Free Cash Flow
AXGN
AXGN
CLPR
CLPR
Q1 26
$-1.4M
Q4 25
$1.8M
Q3 25
$1.7M
Q2 25
$7.0M
Q1 25
$-13.4M
$-4.6M
Q4 24
$8.1M
$-37.9M
Q3 24
$3.3M
Q2 24
$3.3M
FCF Margin
AXGN
AXGN
CLPR
CLPR
Q1 26
-2.3%
Q4 25
3.0%
Q3 25
2.8%
Q2 25
12.4%
Q1 25
-27.7%
-11.7%
Q4 24
16.3%
-99.5%
Q3 24
6.8%
Q2 24
6.8%
Capex Intensity
AXGN
AXGN
CLPR
CLPR
Q1 26
Q4 25
2.1%
Q3 25
2.5%
Q2 25
1.3%
Q1 25
0.5%
28.6%
Q4 24
1.4%
183.3%
Q3 24
1.2%
Q2 24
1.9%
Cash Conversion
AXGN
AXGN
CLPR
CLPR
Q1 26
Q4 25
Q3 25
4.55×
Q2 25
13.35×
Q1 25
Q4 24
19.41×
Q3 24
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AXGN
AXGN

Segment breakdown not available.

CLPR
CLPR

Residential Segment$30.8M83%
Commercial Real Estate$6.2M17%

Related Comparisons